Contact Us
Phase-Xs | Biologics & Biosimilars | Coherent Market Insights
  • Choose License Type

The Global Acellular Dermal Matrices Market, by Origin (Human Dermis, Porcine Dermis, and Bovine Dermis), by Application (Acute Wounds (Burns, Trauma, Cancers, and Infections) Chronic Wounds (Diabetic Foot Ulcers, Venous Leg Ulcers, Pressure Ulcer, and Others), Reconstruction Procedures (Abdominal Wall Procedures, Breast Procedures, Orthopedic Procedures, and Others), by Place of Setting (Hospitals, Ambulatory Surgical Centers, and Office Based), and by Region (North America, Europe, Asia Pacific, Middle East, Africa, and Latin America)  was valued at US$ 7,014.0 Million in 2021 and is projected to exhibit a CAGR of 12.1% during the forecast period (2021-2028).

The key players operating in the market are focusing on development of technologically advanced acellular dermal matrices in order to expand its product portfolio and increasing their presence in the market, this is expected to propel the market growth over the forecast period. For instance, on January 27, 2021, MedSkin Solutions, a Biologic medical devices and professional and home use skin care products manufacturing company, received 510(k) clearance from the U.S. Food and Drug Administration for its MatriDerm product portfolio. MatriDerm is composed of bovine collagen fibers and bovine elastin, a single-use 3D acellular dermal matrix that is used to manage full thickness and partial wounds. MatriDerm’s technology is supported by more than 150 peer-reviewed published articles and is currently sold worldwide, having treated over 300,000 patients. Thus approval of this 3D acellular dermal matrix is anticipated to drive the market growth over the forecast period.

Global Acellular Dermal Matrices market– Impact of Coronavirus (COVID-19) Pandemic

COVID-19 pandemic has affected various industries globally. The players operating in the global acellular dermal matrices market are facing major challenges on various fronts due to the COVID-19 pandemic. According to the Coronavirus Disease (COVID-19) Weekly Epidemiological Update by the World Health Organization, the number of COVID-19 cases reported globally, as of July 19, 2021, are approximately 190,597,409 confirmed cases with 4,093,145 deaths. COVID–19 pandemic is expected to hamper growth of the global acellular dermal matrices market during the forecast period due to delayed surgical procedures during lockdown. Many general surgery device markets were negatively impacted due to elective procedures being cancelled or postponed to minimize the spread of the virus and to reallocate resources to COVID-19 patients. According to the guidelines published in the American College of Surgeons in March 2020, COVID 19 Pandemic Breast Cancer Consortium updated the guidelines for the management of breast cancer during the COVID-19 pandemic. The consortium did not give permission to hospitals to carry out breast mastectomy, as the hospital resources such as ventilator and other devices were completely used for the COVID-19 management.

Browse 35 Market Data Tables and 31 Figures spread through 271 Pages and in-depth TOC on “ Global Acellular Dermal Matrices market”-  Forecast to 2028,  Global Acellular Dermal Matrices market, by Origin (Human Dermis, Porcine Dermis, and Bovine Dermis), by Application (Acute Wounds (Burns, Trauma, Cancers, and Infections) Chronic Wounds (Diabetic Foot Ulcers, Venous Leg Ulcers, Pressure Ulcer, and Others), Reconstruction Procedures (Abdominal Wall Procedures, Breast Procedures, Orthopedic Procedures, and Others), by Place of Setting (Hospitals, Ambulatory Surgical Centers, and Office Based), and by Region (North America, Europe, Asia Pacific, Middle East, Africa, and Latin America)

To know the latest trends and insights prevalent in the Global Acellular Dermal Matrices market, click the link below:

https://www.coherentmarketinsights.com/market-insight/acellular-dermal-matrices-market-4362

The key players operating in the market are focusing on increasing launches of new products, which is expected to propel the growth of the global acellular dermal matrices market over the forecast period. For instance, in February 2020, Baxter International Inc. received 510(K) approval from the U.S. Food and Drug Administration for its PERI-STRIPS dry staple line reinforcement with VERITAS Collagen Matrix with SECURE GRIP Technology (PSDVSG), which is intended to be used as a prosthesis for the surgical repair of soft tissue deficiencies using surgical staplers, when staple line reinforcement is needed.

Key Takeaways of the Global Acellular Dermal Matrices market:

  • The global acellular dermal matrices market is expected to exhibit a CAGR of 12.1% during the forecast period, owing to the increasing number of cosmetic surgeries. According to the American Society of Plastic Surgeons 2019 report, around 207,862 maxillofacial surgery and 2,721,469 soft tissue filler surgeries were performed in the U.S.
  • Among Origin, human dermis segment is expected to lead the acellular dermal matrices market. Advantages of human dermis origin ADM is that it creates a larger implant pocket, allowing higher intraoperative tissue expander fill volume as compared to other origin derived ADM, this is expected to drive the segment growth over the forecast period.
  • Major players operating in the global acellular dermal matrices market are Integra LifeSciences Corporation, AbbVie Inc., Johnson & Johnson, HansBioMed, Becton, Dickinson and Company, Cook Group, Smith & Nephew Plc., Reprise Biomedical, Organogenesis Holdings Inc., Tissue Regenix, LifeNet Health, Zimmer Biomet Holdings, Inc., Stryker Corporation, MiMedx Group, PolyNovo Limited, Fidia Pharma USA Inc., Baxter International Inc., In2Bones Global, BioHorizons, Inc., Harbor MedTech, Inc., MLM Biologics Inc., Geistlich Pharma AG, Olaregen Therapeutix, Inc., EnColl Corporation, Kerecis limited, DSM, ACell Inc., 3M, Cell Constructs I, LLC, CG bio Inc., and Marine Polymer Technologies, Inc.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner